Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- The Locations section was expanded to include numerous new study sites across the United States and internationally (including Argentina, Australia, Canada, and various European and Asian countries). This broadens access by showing more sites where the COSMIC-312 trial is conducted.SummaryDifference3%

- Check18 days agoChange DetectedCOSMIC-312 results have been posted on the study page, including updated PFS and OS outcomes, and related documents (Study Protocol and SAP) added to the record.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a minor revision update: Revision: v3.3.2 replacing v3.3.1; there is no visible change to core study content, eligibility criteria, or study outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedPublications section now states that items are automatically filled from PubMed. The revision history has been updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a 'Results Submitted' status and updated two Taiwan locations from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736'.SummaryDifference0.2%

- Check61 days agoChange DetectedNo significant changes detected; the page content and structure appear the same as before, including study title, design, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.